← back to search

Hua Wu

Nantong University · CN
Area of research
Cancer Research · Genetics
Research interest
Research interests include Medicine, Ebola virus, Virology, Internal medicine, Asymptomatic, and Retrospective cohort study.
h-index
citations
306
works
10
NIH funding
primary concept
email

Recent publications

FAP-targeted radioligand therapy with <sup>68</sup>Ga/<sup>177</sup>Lu-DOTA-2P(FAPI)<sub>2</sub> enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
Journal for ImmunoTherapy of Cancer 2025cited by 24position: middledoi
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Signal Transduction and Targeted Therapy 2024cited by 56position: middledoi
Incidence of suicide mortality among childhood cancer survivors: A population-based retrospective study
Psychiatry Research 2021cited by 9position: middledoi
Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer
Frontiers in Molecular Biosciences 2021cited by 9position: lastdoi
The Association Between Heavy Alcohol Use and Gastric Cancer
The American Journal of Gastroenterology 2021cited by 5position: firstdoi
Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital
PLoS ONE 2020cited by 95position: middledoi
MiR-31 aggravates inflammation and apoptosis in COPD rats via activating the NF-κB signaling pathway
DOAJ (DOAJ: Directory of Open Access Journals) 2020cited by 10position: first
Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
Scientific Reports 2018cited by 29position: middledoi
Diagnostic value of medical thoracoscopy for undiagnosed pleural effusions
Experimental and Therapeutic Medicine 2018cited by 17position: middledoi
miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3
Oncology Letters 2017cited by 35position: middledoi
The Relationship Between Osteomyelitis Complication and Drug-Resistant Infection Risk in Diabetic Foot Ulcer: A Meta-analysis
The International Journal of Lower Extremity Wounds 2017cited by 21position: middledoi
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle
Scientific Reports 2016cited by 43position: middledoi
Significance of Trask protein interactions in brain metastatic cohorts of lung cancers
Tumor Biology 2015cited by 8position: firstdoi
Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China
BMC Nephrology 2013cited by 15position: middledoi
Rapidly Progressive Diffuse Cystic Lesions as a Radiological Hallmark of Lung Adenocarcinoma
Journal of Thoracic Oncology 2012cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shu‐Mei Yang · Shanxi Medical University3 papers (2015–2018)Sun Gang · Shanxi Medical University2 papers (2012–2015)Richard W. Compans · Emory University2 papers (2016–2018)Guoqiang Su · Guangxi University2 papers (2024–2025)Yizhen Pang · National University of Singapore2 papers (2024–2025)Jun Wang · University of Illinois Chicago2 papers (2015–2018)Xiaoyuan Chen · National University of Singapore2 papers (2024–2025)Gale Smith · Novavax (United States)2 papers (2016–2018)Chinglai Yang · Emory University2 papers (2016–2018)Hong‐Lin Chen · Dalian Medical University2 papers (2021–2021)Yangfan Zhou · Guangdong University of Technology2 papers (2024–2025)Haojun Chen · Xiamen University2 papers (2024–2025)Gregory M. Glenn · Novavax (United States)2 papers (2016–2018)Shui-li Wang · Shanxi Medical University1 papers (2015–2015) · 1 papers (2012–2012)Andrew S. Herbert · The Geneva Foundation1 papers (2016–2016)Ralph A. Tripp · University of Georgia1 papers (2016–2016)Yong‐Qing Zhang · Shanxi Medical University1 papers (2018–2018) · 1 papers (2016–2016)Helena Legido‐Quigley · National University of Singapore1 papers (2020–2020)